A tireless researcher in psychopharmacology and a gold-standard philosopher: the scientist and humanist João Romildo Bueno (1938-2019)
DOI:
https://doi.org/10.25118/2763-9037.2019.v9.48Abstract
Professor - João Romildo Bueno (07/08/1938 – 17/08/2019), mineiro da cidade de Cambuí no sul de Minas Gerais, Brasil.
Downloads
Metrics
References
Bueno JR, Himwich HE. A dualisti c approach to some biochemical problems in endogenous depressions. Psychosomati cs. 1967;8:82-94. DOI: https://doi.org/10.1016/S0033-3182(67)72028-9
Spaide J, Tanimukai H, Bueno JR, Himwich HE. Behavioral and biochemical alterati ons in schizophrenic pati ents. Arch Gen Psychiatry. 1968;18:658-65. DOI: https://doi.org/10.1001/archpsyc.1968.01740060018003
Bueno JR, Teixeira AR, Fernandes MF. An experimental evaluati on of the anti -anxiety eff ects of some anti depressants. J Bras Psiquiatr. 1971;20:179-91.
Tanimukai H, Ginther R, Spaide J, Bueno JR, Himwich HE. Detecti on of psychotomimeti c N,N-dimethylated indoleamines in the urine of four schizophrenic pati ents. Br J Psychiatry. 1970;117:421-30. DOI: https://doi.org/10.1192/bjp.117.539.421
Appolinario JC, Bueno JR, Couti nho W. Psychotropic drugs in the treatment of obesity: what promise? CNS Drugs. 2004;18:629-51. DOI: https://doi.org/10.2165/00023210-200418100-00002
Versiani M, Bueno JR, Mundim FD, da Silva JA, Rocha AV. A double-blind comparison between loxapine and chlordiazepoxide in the treatment of neuroti c anxiety. Curr Ther Res Clin Exp. 1976;20:701-15.
de Oliveira IR, Elkis H, Gatt az WF, Chaves A, de Sena EP, de Matos E Souza FG, et al. Aripiprazole for pati ents with schizophrenia and schizoaff ecti ve disorder: an open-label, randomized, study versus haloperidol. CNS Spectr. 2009;14:93-102. DOI: https://doi.org/10.1017/S1092852900000249
Ferreira-Garcia R, da Rocha Freire RC, Appolinário JC, Levitan MN, Halkjær-Lassen RD, Bueno JR, et al. Tranylcypromine plus amitriptyline for electroconvulsive therapy-resistant depression: a long-term study. J Clin Psychopharmacol. 2018;38:502-4. DOI: https://doi.org/10.1097/JCP.0000000000000945
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
